Healthcare Industry News: chronic kidney disease
News Release - April 3, 2007
Sorin Group Names Dick Ames Senior Vice President For U.S. Cardiac Rhythm ManagementMILAN, Italy--(HSMN NewsFeed)--The Sorin Group (MIL:SRN) is pleased to announce the appointment of Richard (Dick) R. Ames as Senior Vice President, U.S. Cardiac Rhythm Management (CRM), effective immediately. The move demonstrates the Sorin Group's commitment to this important, ever-growing market for CRM medical devices.
With 30 years of demonstrated leadership in the CRM industry in companies such as Medtronic, Intermedics and, most recently, St. Jude Medical, Ames joins the Sorin Group CRM Business Unit -- the world's fastest growing CRM company in 2006 -- with a proven track record in sales and marketing experience in the field.
Ames will leverage his past expertise in the CRM industry to build a strong sales force in the U.S. market, a top priority for the Sorin Group management team.
"The U.S. CRM medical device market was valued at approximately $6 billion last year and is expected to continue to grow over the next 5 years. Thanks to our cutting-edge product range and outstanding research and development in CRM, we are determined to be part of this growth. We are certain that Dick is the man who can make it happen," declared Drago Cerchiari, Sorin Group Chief Executive Officer.
"I couldn't be happier to join Sorin and to be part of the ambitious growth plan for the CRM business in the U.S.," Dick Ames commented. "The Group has a fantastic product line-up and a top-notch management team. I am really looking forward to the challenge, drawing on my experience in the industry over the past few decades."
About the Sorin Group:
The Sorin Group (Bloomberg: SRN.IM; Reuters: SORN.MI), a world leader in the development of medical technologies for cardiac surgery, offers innovative therapies for cardiac rhythm dysfunctions, interventional cardiology and the treatment of chronic kidney diseases. The Sorin Group includes: Dideco, CarboMedics, Inc., COBE Cardiovascular, Inc., Stockert, Mitroflow, ELA Medical, Inc., Sorin Biomedica, Bellco and Soludia. It has more than 4,500 employees working at facilities in more than 80 countries throughout the world to serve over 5,000 public and private treatment centers.
For more information, please visit our web site www.sorin.com or www.sorin-crm.com
Source: Sorin Group
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.